Back
Viridian Therapeutics Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
VRDN
Viridian Therapeutics
Last Price:
$17.07
Seasonality Move:
-12.23%
7 Day Trial
ALL ACCESS PASS
$
7
Viridian Therapeutics Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics has on average historically fallen by 15.2% based on the past 11 years of stock performance.
-
Viridian Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Viridian Therapeutics Stock Undervalued?The current Viridian Therapeutics [VRDN] share price is $17.05. The Score for VRDN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
VRDN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics has on average historically fallen by 15.2% based on the past 11 years of stock performance.
Viridian Therapeutics Stock Rating
Sell
37
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics overpriced?
-
Viridian Therapeutics has fallen lower in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Viridian Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
27.20
52-Week Low:
9.90
Prediction Charts
Market Cap:
1.4B
Price in USD:
17.05
Volume:
419.2K
Beta:
1.23
Technical Analysis
SMA50:
14.58
SMA100:
14.37
SMA200:
17.53
52-Wk Change:
11.88%
Stock Predictions
-
Is Viridian Therapeutics stock public?Yes, Viridian Therapeutics is a publicly traded company.
-
What is the Viridian Therapeutics stock quote today?The Viridian Therapeutics stock price is 17.05 USD today.
-
How to buy Viridian Therapeutics stock online?You can buy Viridian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-27 | 14.67 | 14.33 | 14.79 | 14.22 |
Jun-30 | 14.40 | 13.98 | 14.71 | 13.92 |
Jul-1 | 13.90 | 14.47 | 14.91 | 13.84 |
Jul-2 | 14.49 | 15.23 | 15.59 | 14.33 |
Jul-3 | 15.17 | 15.67 | 15.94 | 14.98 |
Jul-7 | 15.49 | 15.89 | 16.07 | 15.36 |
Jul-8 | 15.97 | 16.05 | 16.27 | 15.69 |
Jul-9 | 16.19 | 17.04 | 17.53 | 16.12 |
Jul-10 | 16.92 | 17.13 | 17.32 | 16.66 |
Jul-11 | 16.93 | 17.04 | 17.39 | 16.78 |
Jul-14 | 17.07 | 17.14 | 17.48 | 16.93 |
Jul-15 | 17.15 | 16.26 | 17.34 | 15.97 |
Jul-16 | 16.42 | 16.79 | 17.10 | 16.42 |
Jul-17 | 16.89 | 17.05 | 17.26 | 16.84 |
Viridian Therapeutics Earnings
Viridian Therapeutics Earnings Report: Per Share Viridian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics Forecast Revenue Growth
Viridian Therapeutics Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.02 per share, and an increase next year of $0.31 per share.
* Viridian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.